PUBLISHER: Value Market Research | PRODUCT CODE: 1421045
PUBLISHER: Value Market Research | PRODUCT CODE: 1421045
Global Therapeutic Plasma Exchange Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
The global demand for Therapeutic Plasma Exchange Market is presumed to reach the market size of nearly USD 5.17 BN by 2032 from USD 2.53 BN in 2023 with a CAGR of 8.26% under the study period 2024 - 2032.
Therapeutic plasma exchange (TPE), also known as plasmapheresis, is a medical procedure that removes, treats, retreturnsatient's blood plasma. The primary objective of TPE is to modify the composition of the patient's blood by selectively removing plasma components, such as antibodies, immune complexes, and other substances that may contribute to various medical conditions. The procedure involves a device known as a centrifuge, which separates blood into its components, allowing the targeted removal of plasma.
MARKET DYNAMICS
The Therapeutic plasma exchange market is driven by the increasing prevalence of autoimmune disorders, neurological diseases, and neuromuscular conditions. The growth is propelled by advancements in medical technology, leading to more efficient TPE equipment and improved patient outcomes. Expanding applications in nephrology for treating kidney disorders, coupled with rising awareness among healthcare professionals and patients, contribute to the market's expansion. The aging global population, with a higher susceptibility to autoimmune and neurological disorders, fuels the demand for TPE interventions. Increased healthcare expenditure, government initiatives, and collaborations between healthcare institutions and research organizations support the accessibility of TPE. Clinical research and treatment guidelines play a pivotal role in shaping the market, along with patient preferences for non-invasive treatments. Additionally, the global impact of infectious diseases emphasizes the need for versatile treatment options, further contributing to the dynamic growth of the Therapeutic plasma exchange market.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of therapeutic plasma exchange. The growth and trends of therapeutic plasma exchange industry provide a holistic approach to this study.
MARKET SEGMENTATION
This section of the therapeutic plasma exchange market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Disease Indication
- Neurological Disorders (Chronic Infiommatory Domyelinating Polyneuropathy, Myasthenia Grav, Multiple Secrosis, Neuromyelitis Optica, Guillain-Barre Syndrome)
- Renal Disorders (Post-Renal Transplant Rejection, Anti-Glomerular Basement Membrane (Gsm) Disease, Wegener'S Granulomatosis)
- Hematology Disorders (Thrombotic Thrombocytopenic Purpura, Hemalytic Uremic Syndrome, Cryngichulinemia, Multiple Myeloma, Metabolic Disorders, Homozygous Femilial Hypercholesterolemie, Fulminent Wiburn'S Disease)
- Others
By End-User
- Hospitals
- Specialty Chnics
- Ambulatory Surgice Centers
REGIONAL ANALYSIS
This section covers the regional outlook, which accentuates current and future demand for the Therapeutic Plasma Exchange market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Therapeutic Plasma Exchange market include Asahi Kasei Corporation, Baxter International Inc, Terumo Corporation, B. Braun SE, Fresenius Kabi AG, SB-Kawasumi Laboratories Inc., Haemonetics Corporation, Cerus Corporation, Charles River Laboratories, Medica S.p.A. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
TABLE OF CONTENTS
1 . PREFACE
- 1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
- 2.1. Highlights of Market
- 2.2. Global Market Snapshot
3 . THERAPEUTIC PLASMA EXCHANGE - INDUSTRY ANALYSIS
- 3.1. Introduction - Market Dynamics
- 3.2. Market Drivers
- 3.3. Market Restraints
- 3.4. Opportunities
- 3.5. Industry Trends
- 3.6. Porter's Five Force Analysis
- 3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Disease Indication
- 3.7.2 Market Attractiveness Analysis By End-user
- 3.7.3 Market Attractiveness Analysis By Region
4 . VALUE CHAIN ANALYSIS
- 4.1. Value Chain Analysis
- 4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
- 4.3. List of Potential Buyers
- 4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend
5 . GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET ANALYSIS BY DISEASE INDICATION
- 5.1 Overview by Disease Indication
- 5.2 Historical and Forecast Data
- 5.3 Analysis by Disease Indication
- 5.4 Neurological Disorders (Chronic infiommatory Domyelinating Polyneuropathy, Myasthenia Grav, Multiple Secrosis, Neuromyelitis Optica, Guillain-Barre Syndrome) Historic and Forecast Sales by Regions
- 5.5 Renal Disorders (Post-renal Transplant Rejection, Anti-glomerular Basement Membrane (GSM) Disease, Wegener's Granulomatosis) Historic and Forecast Sales by Regions
- 5.6 Hematology Disorders (Thrombotic Thrombocytopenic Purpura, Hemalytic Uremic Syndrome, Cryngichulinemia, Multiple Myeloma, Metabolic Disorders, Homozygous Femilial Hypercholesterolemie, Fulminent Wiburn's Disease) Historic and Forecast Sales by Regions
- 5.7 Others Historic and Forecast Sales by Regions
6 . GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET ANALYSIS BY END-USER
- 6.1 Overview by End-user
- 6.2 Historical and Forecast Data
- 6.3 Analysis by End-user
- 6.4 Hospitals Historic and Forecast Sales by Regions
- 6.5 Specialty Chnics Historic and Forecast Sales by Regions
- 6.6 Ambulatory Surgice Centers Historic and Forecast Sales by Regions
7 . GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET ANALYSIS BY GEOGRAPHY
- 7.1. Regional Outlook
- 7.2. Introduction
- 7.3. North America Sales Analysis
- 7.3.1. Overview, Historic and Forecast Data Sales Analysis
- 7.3.2. North America By Segment Sales Analysis
- 7.3.3. North America By Country Sales Analysis
- 7.3.4. United State Sales Analysis
- 7.3.5. Canada Sales Analysis
- 7.3.6. Mexico Sales Analysis
- 7.4. Europe Sales Analysis
- 7.4.1. Overview, Historic and Forecast Data Sales Analysis
- 7.4.2. Europe by Segment Sales Analysis
- 7.4.3. Europe by Country Sales Analysis
- 7.4.4. United Kingdom Sales Analysis
- 7.4.5. France Sales Analysis
- 7.4.6. Germany Sales Analysis
- 7.4.7. Italy Sales Analysis
- 7.4.8. Russia Sales Analysis
- 7.4.9. Rest Of Europe Sales Analysis
- 7.5. Asia Pacific Sales Analysis
- 7.5.1. Overview, Historic and Forecast Data Sales Analysis
- 7.5.2. Asia Pacific by Segment Sales Analysis
- 7.5.3. Asia Pacific by Country Sales Analysis
- 7.5.4. China Sales Analysis
- 7.5.5. India Sales Analysis
- 7.5.6. Japan Sales Analysis
- 7.5.7. South Korea Sales Analysis
- 7.5.8. Australia Sales Analysis
- 7.5.9. South East Asia Sales Analysis
- 7.5.10. Rest Of Asia Pacific Sales Analysis
- 7.6. Latin America Sales Analysis
- 7.6.1. Overview, Historic and Forecast Data Sales Analysis
- 7.6.2. Latin America by Segment Sales Analysis
- 7.6.3. Latin America by Country Sales Analysis
- 7.6.4. Brazil Sales Analysis
- 7.6.5. Argentina Sales Analysis
- 7.6.6. Peru Sales Analysis
- 7.6.7. Chile Sales Analysis
- 7.6.8. Rest of Latin America Sales Analysis
- 7.7. Middle East & Africa Sales Analysis
- 7.7.1. Overview, Historic and Forecast Data Sales Analysis
- 7.7.2. Middle East & Africa by Segment Sales Analysis
- 7.7.3. Middle East & Africa by Country Sales Analysis
- 7.7.4. Saudi Arabia Sales Analysis
- 7.7.5. UAE Sales Analysis
- 7.7.6. Israel Sales Analysis
- 7.7.7. South Africa Sales Analysis
- 7.7.8. Rest Of Middle East And Africa Sales Analysis
8 . COMPETITIVE LANDSCAPE OF THE THERAPEUTIC PLASMA EXCHANGE COMPANIES
- 8.1. Therapeutic Plasma Exchange Market Competition
- 8.2. Partnership/Collaboration/Agreement
- 8.3. Merger And Acquisitions
- 8.4. New Product Launch
- 8.5. Other Developments
9 . COMPANY PROFILES OF THERAPEUTIC PLASMA EXCHANGE INDUSTRY
- 9.1. Top Companies Market Share Analysis
- 9.2. Market Concentration Rate
- 9.3. Asahi Kasei Corporation
- 9.3.1. Company Overview
- 9.3.2. Company Revenue
- 9.3.3. Products
- 9.3.4. Recent Developments
- 9.4. Baxter International Inc
- 9.4.1. Company Overview
- 9.4.2. Company Revenue
- 9.4.3. Products
- 9.4.4. Recent Developments
- 9.5. Terumo Corporation
- 9.5.1. Company Overview
- 9.5.2. Company Revenue
- 9.5.3. Products
- 9.5.4. Recent Developments
- 9.6. B. Braun SE
- 9.6.1. Company Overview
- 9.6.2. Company Revenue
- 9.6.3. Products
- 9.6.4. Recent Developments
- 9.7. Fresenius Kabi AG
- 9.7.1. Company Overview
- 9.7.2. Company Revenue
- 9.7.3. Products
- 9.7.4. Recent Developments
- 9.8. SB-Kawasumi Laboratories Inc.
- 9.8.1. Company Overview
- 9.8.2. Company Revenue
- 9.8.3. Products
- 9.8.4. Recent Developments
- 9.9. Haemonetics Corporation
- 9.9.1. Company Overview
- 9.9.2. Company Revenue
- 9.9.3. Products
- 9.9.4. Recent Developments
- 9.10. Cerus Corporation
- 9.10.1. Company Overview
- 9.10.2. Company Revenue
- 9.10.3. Products
- 9.10.4. Recent Developments
- 9.11. Charles River Laboratories
- 9.11.1. Company Overview
- 9.11.2. Company Revenue
- 9.11.3. Products
- 9.11.4. Recent Developments
- 9.12. Medica S.p.A
- 9.12.1. Company Overview
- 9.12.2. Company Revenue
- 9.12.3. Products
- 9.12.4. Recent Developments
Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
LIST OF TABLES
- Market Snapshot
- Drivers : Impact Analysis
- Restraints : Impact Analysis
- List of Raw Material
- List of Raw Material Manufactures
- List of Potential Buyers
- Analysis by Disease Indication (USD MN)
- Neurological Disorders (Chronic infiommatory Domyelinating Polyneuropathy, Myasthenia Grav, Multiple Secrosis, Neuromyelitis Optica, Guillain-Barre Syndrome) Market Sales by Geography (USD MN)
- Renal Disorders (Post-renal Transplant Rejection, Anti-glomerular Basement Membrane (GSM) Disease, Wegener's Granulomatosis) Market Sales by Geography (USD MN)
- Hematology Disorders (Thrombotic Thrombocytopenic Purpura, Hemalytic Uremic Syndrome, Cryngichulinemia, Multiple Myeloma, Metabolic Disorders, Homozygous Femilial Hypercholesterolemie, Fulminent Wiburn's Disease) Market Sales by Geography (USD MN)
- Others Market Sales by Geography (USD MN)
- Analysis Market by End-user (USD MN)
- Hospitals Market Sales by Geography (USD MN)
- Specialty Chnics Market Sales by Geography (USD MN)
- Ambulatory Surgice Centers Market Sales by Geography (USD MN)
- Global Therapeutic Plasma Exchange Market Sales by Geography (USD MN)
- North America Market Analysis (USD MN)
- United State Market Analysis (USD MN)
- Canada Market Analysis (USD MN)
- Mexico Market Analysis (USD MN)
- Europe Market Analysis (USD MN)
- Europe Market Estimate by Country (USD MN)
- United Kingdom Market Analysis (USD MN)
- France Market Analysis (USD MN)
- Germany Market Analysis (USD MN)
- Italy Market Analysis (USD MN)
- Russia Market Analysis (USD MN)
- Spain Market Analysis (USD MN)
- Rest of Europe Market Analysis (USD MN)
- Asia Pacific Market Analysis (USD MN)
- China Market Analysis (USD MN)
- Japan Market Analysis (USD MN)
- India Market Analysis (USD MN)
- South Korea Market Analysis (USD MN)
- Australia Market Analysis (USD MN)
- South East Asia Market Analysis (USD MN)
- Rest of Asia Pacific Market Analysis (USD MN)
- Latin America Market Analysis (USD MN)
- Brazil Market Analysis (USD MN)
- Argentina Market Analysis (USD MN)
- Peru Market Analysis (USD MN)
- Chile Market Analysis (USD MN)
- Rest of Latin America Market Analysis (USD MN)
- Middle East & Africa Market Analysis (USD MN)
- Saudi Arabia Market Analysis (USD MN)
- UAE Market Analysis (USD MN)
- Israel Market Analysis (USD MN)
- South Africa Market Analysis (USD MN)
- Rest of Middle East and Africa Market Analysis (USD MN)
- Partnership/Collaboration/Agreement
- Mergers And Acquisition
LIST OF FIGURES
- Research Scope of Therapeutic Plasma Exchange Report
- Market Research Process
- Market Research Methodology
- Global Therapeutic Plasma Exchange Market Size, by Region (USD MN)
- Porters Five Forces Analysis
- Market Attractiveness Analysis by Disease Indication
- Market Attractiveness Analysis by End-user
- Market Attractiveness Analysis by Region
- Value Chain Analysis
- Global Market Analysis by Disease Indication (USD MN)
- Neurological Disorders (Chronic infiommatory Domyelinating Polyneuropathy, Myasthenia Grav, Multiple Secrosis, Neuromyelitis Optica, Guillain-Barre Syndrome) Market Sales by Geography (USD MN)
- Renal Disorders (Post-renal Transplant Rejection, Anti-glomerular Basement Membrane (GSM) Disease, Wegener's Granulomatosis) Market Sales by Geography (USD MN)
- Hematology Disorders (Thrombotic Thrombocytopenic Purpura, Hemalytic Uremic Syndrome, Cryngichulinemia, Multiple Myeloma, Metabolic Disorders, Homozygous Femilial Hypercholesterolemie, Fulminent Wiburn's Disease) Market Sales by Geography (USD MN)
- Others Market Sales by Geography (USD MN)
- Global Market Analysis by End-user (USD MN)
- Hospitals Market Sales by Geography (USD MN)
- Specialty Chnics Market Sales by Geography (USD MN)
- Ambulatory Surgice Centers Market Sales by Geography (USD MN)
- Global Market Sales (USD MN)
- North America Market Sales (USD MN)
- Europe Market Sales (USD MN)
- Asia Pacific Market Sales (USD MN)
- Latin America Market Sales (USD MN)
- Middle East & Africa Market Sales (USD MN)
- Recent Development in Industry
- Top Companies Market Share Analysis
Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.
